The reassessment of Leqembi’s safety data follows the agency’s previous recommendation of the drug for use in the EU.

The novel formulation of rizatriptan and meloxicam (Symbravo, Axome Therapeutics) is for the acute treatment of migraine with ...

New research showed some long COVID patients get symptom relief by taking an extended course of Paxlovid. Data are ...

Suzetrigine selectively inhibits the NaV1.8 pain-signaling pathway in the peripheral nervous system and provides effective ...

A pilot trial will assess whether concentrated bone marrow aspirate can prevent inflammation and reduce postsurgery pain and ...

The European Medicines Agency has recommended three new medicines to treat breast and cervical cancer and ...

Thyroid disease is often missed in older adults because its symptoms overlap with those of “normal aging.” In this ...

Researchers have made strides creating strong, long-lasting imitation muscle as science fiction slowly evolves into fact.

The European Medicines Agency’s positive opinion for ivermectin-albendazole for treating soil-transmitted helminth infections ...

Marketing authorization for the first EU vaccine to protect adolescents against chikungunya has been expedited for its public ...

A recent survey revealed that many patients were worried about the physical effects of radiation, and more than one third ...

Increased menstrual blood loss can be hard to measure and may detract from a woman’s quality of life, but a range of ...